Volume 17, Issue 5

Search all Hepatology International articles

October 2023

29 articles in this issue

Consensus on the tertiary prevention of primary liver cancer
Yuemin Nan
Xiaoyuan Xu
Chinese Society of Hepatology, Chinese Medical Association
Consensus Open access 27 June 2023 Pages: 1057 - 1071
HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence
Bruno Roche
Didier Samuel
Editorial 23 June 2023 Pages: 1072 - 1074
Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B
Suzanne Faure-Dupuy
Thomas F. Baumert
Editorial 27 June 2023 Pages: 1075 - 1078
Prospects for treatment of esophageal varices considering the safety of endoscopic band ligation
Tomohiro Katsumi
Yoshiyuki Ueno
Editorial 08 July 2023 Pages: 1079 - 1081
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
Karl Vaz
Daniel Clayton-Chubb
Stuart K. Roberts
Review Article Open access 09 August 2023 Pages: 1082 - 1097
Management of adults with Alagille syndrome
Mohammed D. Ayoub
Ahmad A. Bakhsh
Binita M. Kamath
Review Article Open access 16 August 2023 Pages: 1098 - 1112
High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis
Li-Ping Sheng
Jun-Chang Zhang
Gui-Qiang Wang
Original Article 02 January 2023 Pages: 1113 - 1124
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B
Yu-Long Fu
Shuang-Nan Zhou
Chao Zhang
Original Article Open access 28 March 2023 Pages: 1125 - 1138
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
Shang-Chin Huang
Tung-Hung Su
Jia-Horng Kao
Original Article 29 May 2023 Pages: 1139 - 1149
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
Yu Jun Wong
Sally Tran
Mindie H. Nguyen
Original Article 05 June 2023 Pages: 1150 - 1161
Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease
Zhengyi Wang
Gary P. Jeffrey
Leon A. Adams
Original Article Open access 26 June 2023 Pages: 1162 - 1169
Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis
Wenyan Zhang
Jing Zhang
Hongbo Shi
Original Article 06 June 2023 Pages: 1170 - 1181
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study
Jiarong Xie
Lei Xu
Chengfu Xu
Original Article 15 June 2023 Pages: 1182 - 1191
Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study
Yong Lv
Wei Bai
Guohong Han
Original Article 31 May 2023 Pages: 1192 - 1204
Endoscopic band ligation is safe despite low platelet count and high INR
Nikolaus Pfisterer
Michael Schwarz
Thomas Reiberger
Original Article Open access 06 April 2023 Pages: 1205 - 1214
Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
Atsushi Oyama
Akinobu Takaki
Motoyuki Otsuka
Original Article Open access 26 July 2023 Pages: 1215 - 1224
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
Serami Murakami
Michio Imamura
Shiro Oka
Original Article 26 April 2023 Pages: 1225 - 1232
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure
Anand V. Kulkarni
Raghuram Reddy
K. Rajender Reddy
Original Article 05 June 2023 Pages: 1233 - 1240
Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study
Xiao-hao Wang
Bin-bin Peng
Shan Zhong
Original Article 07 August 2023 Pages: 1241 - 1250
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study
Shi-Ye Yang
Jin-Kai Feng
Wei-Xing Guo
Original Article 15 April 2023 Pages: 1251 - 1264
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1
Jie Hu
Wei-Feng Liu
Jian Zhou
Original Article 28 April 2023 Pages: 1265 - 1278
Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Renguo Guan
Jie Mei
Rongping Guo
Original Article 02 May 2023 Pages: 1279 - 1288
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma
Issei Saeki
Yutaka Suehiro
Takahiro Yamasaki
Original Article 25 April 2023 Pages: 1289 - 1299
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
Zimin Song
Shuirong Lin
Shunli Shen
Original Article Open access 27 June 2023 Pages: 1300 - 1317
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark?
Prajna Anirvan
Manas Kumar Panigrahi
Shivaram Prasad Singh
Letter to the Editor 24 April 2023 Pages: 1318 - 1319
Reply to: “developing real‑world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond”
Takeshi Hatanaka
Satoru Kakizaki
Takashi Kumada
Letter to the Editor 03 June 2023 Pages: 1320 - 1321
Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues”
Shi-Ye Yang
Jin-Kai Feng
Wei-Xing Guo
Letter to the Editor 04 March 2023 Pages: 1322 - 1323
HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold
Edoardo G. Giannini
Quirino Lai
Letter to the Editor 02 March 2023 Pages: 1324 - 1325
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
Serami Murakami
Michio Imamura
Shiro Oka
Correction 12 June 2023 Pages: 1326 - 1326

Volume 17, Issue 5

Consensus on the tertiary prevention of primary liver cancer

HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence

Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B

Prospects for treatment of esophageal varices considering the safety of endoscopic band ligation

Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes

Management of adults with Alagille syndrome

High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis

Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B

Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study

Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease

Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis

A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study

Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study

Endoscopic band ligation is safe despite low platelet count and high INR

Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan

Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure

Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure

Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study

Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study

Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1

Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?

Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes

Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark?

Reply to: “developing real‑world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond”

Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues”

HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold

Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure

Navigation